MedTrace Logo

Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer

NCT05253716 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 696

Last updated 2022-08-29

No results posted yet for this study

Summary

Gastric cancer patients with stage III will be randomized to immune nutrition support or control group at discharge after total gastrectomy. Patients will receive 6 months of immune nutrition support or normal diet after discharge. The primary and secondary outcomes will be collected.

Conditions

  • Stage III Gastric Cancer

Interventions

OTHER

ONS

Immunonutritional supplement

Sponsors & Collaborators

  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER

  • The Affiliated cancer hospital of Nanjing Medical University

    collaborator UNKNOWN

  • Nanjing Jiangning Hospital

    collaborator UNKNOWN

  • Zhenjiang First People's Hospital

    collaborator OTHER

  • The Third Affiliated Hospital of Soochow University

    collaborator OTHER

  • ChangZhou Second hospital

    collaborator UNKNOWN

  • The First Affiliated Hospital of Soochow University

    collaborator OTHER

  • Second Affiliated Hospital of Soochow University

    collaborator OTHER

  • Yixing People's Hospital

    collaborator OTHER

  • The Second Hospital of Nanjing Medical University

    collaborator OTHER

  • Wuxi People's Hospital

    collaborator OTHER

  • Jinling Hospital, China

    lead OTHER

Principal Investigators

  • Xinying Wang, MD · Jinling Hosptial

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05253716 on ClinicalTrials.gov